Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis?

References

1. ↵
   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–27

   CrossRefPubMedWeb of Science
2. ↵
   Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002;52:47–53

   CrossRefPubMedWeb of Science
3. ↵
   Tintoré M, Rovira A, Río J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003;60:27–30

   Abstract/FREE Full Text
4. ↵
   Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059–69

   Abstract/FREE Full Text
5. ↵
   Tintoré M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000;21:702–06

   Abstract/FREE Full Text
6. ↵
   Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:602–11

   Abstract/FREE Full Text
7. ↵
   Miller DH, Filippi M, Fazekas F, et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004;56:273–78

   CrossRefPubMedWeb of Science
8. ↵
   Frayne R, Goodyear BG, Dickhoff P, et al. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003;38:385–402

   CrossRefPubMed
9. ↵
   Norris DG. High field human imaging. J Magn Reson Imaging 2003;18:519–29

   CrossRefPubMedWeb of Science
10. ↵
    Schima W, Wimberger D, Schneider B, et al. The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5T and 1.5T. RoFo 1993;158:368–71

    PubMed
11. Filippi M, van Waesberghe JH, Horsfield MA, et al. Interscanner variation in brain MRI lesion load measurements in MS. Neurology 1997;49:371–77

    Abstract/FREE Full Text
12. ↵
    Lee DH, Vellet AD, Eliasziw M, et al. MR imaging field: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5T. Radiology 1995;194:257–62

    PubMedWeb of Science
13. ↵
    Keiper MD, Grossmann RI, Hirsch JA, et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5T and 4T. AJNR Am J Neuroradiol 1998;19:1489–93

    Abstract
14. ↵
    Sicotte NL, Voskuhl RR, Bouvier S, et al. Comparison of multiple sclerosis lesions at 1.5 and 3.0T. Invest Radiol 2003;38:423–27

    CrossRefPubMedWeb of Science
15. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52

    Abstract/FREE Full Text
16. ↵
    de Zwart JA, Ledden PJ, Kellman P, et al. Design of a SENSE-optimized high-sensitivity MRI receive coil for brain imaging. Magn Reson Med 2002;47:1218–27

    CrossRefPubMedWeb of Science
17. ↵
    Simon JH, Li D, Traboulsee A, et al. Standarized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines. AJNR Am J Neuroradiol 2006;27:455–61

    FREE Full Text
18. ↵
    Bakshi R, Ariyaratana S, Benedict RH, et al. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742–48

    CrossRefPubMedWeb of Science
19. Molyneux PD, Tubridy N, Parker GJ, et al. The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1715–20

    Abstract
20. ↵
    Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749–54

    CrossRefPubMedWeb of Science
21. ↵
    Jacobs DL, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898–904

    CrossRefPubMedWeb of Science
22. ↵
    Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 2001;357:1576–82

    CrossRefPubMedWeb of Science
23. ↵
    Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a. Ann Neurol 2003;53:718–24

    CrossRefPubMedWeb of Science
24. ↵
    Stone LA, Albert PS, Smith ME, et al. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 1995;45:1808–14

    Abstract/FREE Full Text